World Of Taxonomy
42388-013Level 3

COMETRIQ (cabozantinib)

**Product type:** Human Prescription Drug

**Active ingredient:** CABOZANTINIB S-MALATE

**Strength:** 20 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Exelixis, Inc.

**Marketing category:** NDA (NDA203756)

**Pharmacologic class:** Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/42388-013
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.